Lecia V Sequist Selected Research

Lecia V Sequist Research Topics

Disease

94	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2005
88	Neoplasms (Cancer) 01/2022 - 07/2006
57	Lung Neoplasms (Lung Cancer) 10/2022 - 07/2006
20	Disease Progression 01/2022 - 08/2009
16	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2007
12	Adenocarcinoma of Lung 12/2018 - 07/2007
10	Circulating Neoplastic Cells 10/2018 - 07/2008
6	Adenocarcinoma 01/2019 - 07/2007
6	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 03/2010
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 10/2010
4	Dyspnea (Shortness of Breath) 06/2018 - 09/2013
4	Brain Neoplasms (Brain Tumor) 01/2018 - 11/2014
4	Melanoma (Melanoma, Malignant) 01/2018 - 07/2012
4	Fatigue 11/2016 - 09/2013
3	Central Nervous System Diseases (CNS Diseases) 06/2022 - 01/2018
3	Pneumonia (Pneumonitis) 01/2021 - 05/2008
3	Exanthema (Rash) 01/2020 - 09/2013
3	Epilepsy (Aura) 01/2019 - 04/2017
3	Cough 01/2018 - 09/2013
3	Pain (Aches) 01/2018 - 09/2013
3	Diarrhea 09/2013 - 06/2010
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 02/2015
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 11/2016
2	Neutropenia 11/2016 - 02/2015
2	Stomatitis 02/2015 - 09/2013
2	Acne Vulgaris 02/2015 - 09/2013
2	Nausea 09/2013 - 09/2013
1	COVID-19 01/2021
1	medullary Thyroid cancer 01/2020
1	Pneumothorax 12/2019

Drug/Important Bio-Agent (IBA)

73	ErbB Receptors (EGF Receptor)IBA 01/2021 - 08/2005
48	Tyrosine Kinase InhibitorsIBA 10/2022 - 01/2007
22	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2019 - 07/2006
14	RNA (Ribonucleic Acid)IBA 12/2018 - 03/2010
13	AfatinibIBA 01/2021 - 05/2012
12	osimertinibIBA 06/2022 - 04/2016
11	Pharmaceutical PreparationsIBA 11/2020 - 06/2008
11	Gefitinib (Iressa)FDA Link 01/2019 - 07/2006
10	Phosphotransferases (Kinase)IBA 01/2022 - 08/2005
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2007
9	PlatinumIBA 01/2022 - 02/2010
8	CrizotinibIBA 01/2021 - 06/2010
8	Biological ProductsIBA 11/2020 - 03/2007
8	Anaplastic Lymphoma KinaseIBA 01/2020 - 06/2010
8	Pemetrexed (MTA)FDA Link 11/2016 - 10/2008
7	rociletinibIBA 11/2018 - 01/2015
7	Cisplatin (Platino)FDA LinkGeneric 03/2016 - 11/2008
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2007
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2008
5	Immune Checkpoint InhibitorsIBA 01/2021 - 06/2015
4	Circulating Tumor DNAIBA 01/2020 - 03/2016
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2018 - 07/2012
4	ARQ 197IBA 01/2018 - 08/2011
3	lorlatinibIBA 10/2022 - 01/2021
3	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2008
3	nazartinibIBA 01/2022 - 01/2018
3	pembrolizumabIBA 01/2019 - 11/2016
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019 - 03/2013
3	Docetaxel (Taxotere)FDA Link 01/2019 - 01/2015
3	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2019 - 12/2012
3	Androgen Receptors (Androgen Receptor)IBA 11/2017 - 11/2012
3	Carboplatin (JM8)FDA LinkGeneric 11/2016 - 11/2009
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2010 - 07/2006
2	cabozantinibIBA 01/2022 - 01/2021
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2017
2	olaparibIBA 10/2019 - 10/2013
2	Messenger RNA (mRNA)IBA 01/2019 - 12/2018
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 12/2018 - 01/2018
2	NivolumabIBA 10/2018 - 06/2015
2	Complement System Proteins (Complement)IBA 12/2017 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 11/2017 - 01/2017
2	EpitopesIBA 10/2017 - 04/2013
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2017 - 12/2014
2	alectinibIBA 11/2016 - 10/2016
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2015 - 10/2012
2	AndrogensIBA 09/2015 - 11/2012
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2013 - 11/2010
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	entrectinibIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	capmatinibIBA 01/2021
1	selpercatinibIBA 01/2020
1	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2020
1	SolventsIBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 10/2019
1	IpilimumabIBA 01/2019
1	seribantumabIBA 01/2019
1	histidine-rich proteinsIBA 01/2019

Therapy/Procedure

71	Therapeutics 01/2022 - 07/2006
28	Drug Therapy (Chemotherapy) 01/2022 - 02/2007
9	Radiotherapy 01/2022 - 02/2015
3	Immunotherapy 01/2022 - 01/2015
3	Castration 01/2018 - 11/2012
3	Aftercare (After-Treatment) 01/2018 - 06/2007
3	Lab-On-A-Chip Devices 11/2014 - 07/2008
2	Drug Tapering 01/2020 - 06/2010
1	Surgical Instruments (Clip) 01/2020
1	Chest Tubes (Chest Tube) 12/2019
1	Adjuvant Chemotherapy 10/2019
1	Time-to-Treatment 01/2019